Precision of biomarkers to define chronic inflammation in CKD

American Journal of Nephrology

Volumn 28, Issue 5, 2008, Pages 808-812

  Laclair, Robert ^a   O'Neal, Kalisha ^a   Ofner, Susan ^a   Sosa, Marcelo J ^b   Labarrere, Carlos A ^b   Moe, Sharon M ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METHODIST RESEARCH INSTITUTE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomarkers, precision; Chronic inflammation; Chronic kidney disease; CKD stage 5D; Inflammatory biomarkers, intrapatient variance; Tunneled dialysis catheter

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FETUIN A; INTERLEUKIN 6;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CATHETER INFECTION; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CORRELATION COEFFICIENT; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINARY CATHETER;

BIOLOGICAL MARKERS; BLOOD PROTEINS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; INDIVIDUALITY; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 51149109629     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135692     Document Type: Article

References (18)

1. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-369.
2. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
3. Moe SM, Chen NX: Inflammation and vascular calcification. Blood Purif 2005;23:64-71.
4. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
5. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476.
6. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, et al: Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int Suppl 2002:103-108.
7. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, et al: Association of low fetuin-A concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.
8. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
9. Stenvinkel P: Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant 2002;17(suppl 8):33-40.
10. Franek E, Blaschyk R, Kolonko A, Mazur-Psonka L, et al: Chronic periodontitis in hemodialysis patients with chronic kidney disease is associated with elevated serum C-reactive protein concentration and greater intima-media thickness of the carotid artery. J Nephrol 2006;19:346-351.
11. Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
12. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
13. Ketteler M, Wanner C, Metzger T, Bongartz P, et al: Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int Suppl 2003:S84-S87.
14. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812.
15. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, et al: The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 2004;19:150-157.
16. De Maat MP, de Bart AC, Hennis BC, Meijer P, et al: Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 1996;16:1156-1162.
17. Van Tellingen A, Grooteman MP, Schoorl M, Bartels PC, et al: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 2002;62:632-638.
18. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, et al: Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006;70:345-350.